TechBBQ 2022
TechBBQ is the largest and most ‘hyggelig’ Scandinavian event supporting the Nordic startup ecosystem.
LSX Nordic Congress
The leading senior executive strategy, investment and partnering conference for the Nordic region.
Abzu® is named a “Cool Vendor” in the 2022 Gartner® Cool Vendors™ in AI Governance and Responsible AI — From Principles to Practice report
Abzu® is named a Cool Vendor in the 2022 Gartner® Cool Vendors in AI Governance and Responsible AI — From Principles to Practice report, an annual evaluation of commercial platforms for data science and machine learning (ML), as well as for cloud AI services platforms. These platforms use common open-source libraries for explainability, fairness, and trustworthiness, in addition to their own proprietary approaches.
Abzu appoints Mette Kirstine Agger as a member of the board
The Danish and Spanish AI company Abzu is bringing in an experienced force from biotech and venture-backed research, Mette Kirstine Agger, as a new member of their board. Mette Kirstine Agger was most recently Managing Partner for Lundbeckfonden Ventures, and with her experience in biotech and business development, she intends to strengthen Abzu’s position in the life sciences.
Abzu announces a new location at the Switzerland Innovation Park Basel Area – Novartis Campus
Believing in the European vision for AI This marks Abzu’s third office in Europe and the first expansion of its physical footprint since Abzu’s inception in January 2018 with joint offices in Copenhagen, Denmark and Barcelona, Spain. “Our goal is to become the leading European AI company,” says founder Casper Wilstrup. “Our story is that […]
Accelerating scientific discoveries with explainable AI: A breast cancer example
A 17 minute video about Abzu’s origins and an impactful application in life science.
TechBBQ 2021
Accelerating scientific discoveries with Abzu’s explainable AI: A breast cancer example
TechBBQ 2021
TechBBQ is the largest and most ‘hyggelig’ Scandinavian event supporting the Nordic startup ecosystem.
Abzu and Contera Pharma partner to design RNA therapeutics for rare diseases using xAI technology
Abzu, an applied research startup who has developed a pioneering explainable artificial intelligence (xAI), and Contera Pharma, a biotech company developing innovative therapies to treat neurological disorders, are partnering to design nucleic acid-based medicines. Abzu will collaborate exclusively with Contera Pharma on two undisclosed targets within rare neurological diseases.
Record-breaking investment in groundbreaking Danish AI: Abzu announces a 5.8m € seed round
Denmark-based Abzu®, creator of a revolutionary high-performing, transparent, and explainable AI, has announced a 5.8 million euro seed round led by Seed Capital, Inventure, and PreSeed Ventures. Other notable participants in the round are existing investor Vaekstfonden and angel investors. The round follows Abzu’s increased traction with several of the world’s largest pharmaceutical companies.